PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Sabrautzki, S. ; Rubio-Aliaga, I. ; Hans, W. ; Fuchs, H. ; Rathkolb, B.* ; Calzada-Wack, J. ; Cohrs, C.M. ; Klaften, M. ; Seedorf, H.* ; Eck, S.H. ; Benet-Pagès, A. ; Favor, J. ; Esposito, I. ; Strom, T.M. ; Wolf, E.* ; Lorenz-Depiereux, B. ; Hrabě de Angelis, M.

New mouse models for metabolic bone diseases generated by genome-wide ENU mutagenesis.

Mamm. Genome 23, 416-430 (2012)
DOI PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Metabolic bone disorders arise as primary diseases or may be secondary due to a multitude of organ malfunctions. Animal models are required to understand the molecular mechanisms responsible for the imbalances of bone metabolism in disturbed bone mineralization diseases. Here we present the isolation of mutant mouse models for metabolic bone diseases by phenotyping blood parameters that target bone turnover within the large-scale genome-wide Munich ENU Mutagenesis Project. A screening panel of three clinical parameters, also commonly used as biochemical markers in patients with metabolic bone diseases, was chosen. Total alkaline phosphatase activity and total calcium and inorganic phosphate levels in plasma samples of F1 offspring produced from ENU-mutagenized C3HeB/FeJ male mice were measured. Screening of 9,540 mice led to the identification of 257 phenodeviants of which 190 were tested by genetic confirmation crosses. Seventy-one new dominant mutant lines showing alterations of at least one of the biochemical parameters of interest were confirmed. Fifteen mutations among three genes (Phex, Casr, and Alpl) have been identified by positional-candidate gene approaches and one mutation of the Asgr1 gene, which was identified by next-generation sequencing. All new mutant mouse lines are offered as a resource for the scientific community.
Erratum to: Mamm Genome (2012) 23:416–430 DOI 10.1007/s00335-012-9397-z In Table 3 of the original publication, the ‘Additional phenotype, comment’ for the ‘Line name’ BCH004 should read as follows: Nonsense mutation in exon 4 of the Casr (calcium-sensing receptor) gene, c.1366G > T, p.Glu456X.  
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Altmetric
2.887
0.755
23
Tags
GMC
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter X-Linked Hypophosphatemia; Familial Hypocalciuric Hypercalcemia; Neonatal Severe Hyperparathyroidism; Nonspecific Alkaline-Phosphatase; Calcium-Sensing Receptor; Primordial Germ-Cells; D-Resistant Rickets; Osteogenesis-Imperfecta; Pagets-Disease; Ca2+-Sensing Receptor
Sprache englisch
Veröffentlichungsjahr 2012
HGF-Berichtsjahr 2012
ISSN (print) / ISBN 0938-8990
e-ISSN 1432-1777
Zeitschrift Mammalian Genome
Quellenangaben Band: 23, Heft: 7-8, Seiten: 416-430 Artikelnummer: , Supplement: ,
Verlag Springer
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Experimental Genetics (IEG)
Institute of Pathology (PATH)
Institute of Human Genetics (IHG)
POF Topic(s) 30201 - Metabolic Health
30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
30501 - Systemic Analysis of Genetic and Environmental Factors that Impact Health
Forschungsfeld(er) Genetics and Epidemiology
Enabling and Novel Technologies
PSP-Element(e) G-500600-003
G-500600-001
G-500300-001
G-500700-001
G-500700-002
PubMed ID 22527485
PubMed ID 25100545
DOI 10.1007/s00335-012-9397-z
DOI 10.1007/s00335-014-9534-y
WOS ID WOS:000345422500008
WOS ID WOS:000306694700003
Scopus ID 84865107729
Scopus ID 84912010249
Scopus ID 84905287412
Erfassungsdatum 2012-08-20
[➜Korrektur melden]